rs6439886 — CLSTN2
Intronic variant in the calsyntenin-2 gene associated with episodic memory performance and hippocampal inhibitory circuit function
Details
- Gene
- CLSTN2
- Chromosome
- 3
- Risk allele
- A
- Consequence
- Intronic
- Inheritance
- Codominant
- Clinical
- Risk Factor
- Evidence
- Moderate
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Neurology & CognitionSee your personal result for CLSTN2
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
CLSTN2 — The Synaptic Scaffold Behind Memory Precision
In 2006, the first genome-wide association study of episodic memory in
healthy adults identified two genes linked to how well people remember
verbal information. The first, KIBRA, became famous. The second,
CLSTN211 CLSTN2
Calsyntenin-2 (calsyntenin 2), a postsynaptic transmembrane
protein of the cadherin superfamily expressed exclusively in brain tissue,
received less attention — but has since accumulated its own evidence base
connecting it to memory circuits, inhibitory neuron integrity, and the
hippocampus22 hippocampus
The seahorse-shaped brain structure critical for forming
and retrieving episodic memories — the kind tied to specific events
and experiences.
The Mechanism
CLSTN2 encodes a 955-amino-acid protein with two
cadherin repeats33 cadherin repeats
Structural domains that mediate calcium-dependent
cell-cell adhesion; in neurons they help organize the postsynaptic
density at synaptic junctions,
a transmembrane domain, and a cytoplasmic tail. It is expressed
exclusively in neural tissue, concentrated in the postsynaptic
specializations of excitatory synapses — particularly in layers 5 and 6
of the cerebral cortex and throughout the hippocampus. Despite its location
at excitatory synapses, calsyntenin-2 appears to exert its primary cognitive
influence through a different circuit: it is required for the maintenance of
inhibitory interneurons.
Mouse knockout studies44 Mouse knockout studies
Lipina TV et al. Cognitive Deficits in
Calsyntenin-2-deficient Mice Associated with Reduced GABAergic Transmission.
Neuropsychopharmacology, 2016
showed that complete loss of CLSTN2 reduced the density of
parvalbumin-positive GABAergic interneurons55 parvalbumin-positive GABAergic interneurons
Fast-spiking inhibitory
neurons that generate gamma-frequency oscillations (30-80 Hz) essential
for encoding and retrieving episodic memories; they coordinate excitatory
pyramidal cell firing with millisecond precision
in hippocampal CA1, CA3, and dentate gyrus by 25-56%, with no effect on
other interneuron subtypes (somatostatin, calretinin, calbindin). The result
was a selective reduction in inhibitory postsynaptic currents and impaired
spatial memory on the Morris water maze — while excitatory transmission and
non-spatial cognition remained intact. The SNP rs6439886 sits in the first
intron and does not alter the protein sequence directly; it is presumed to
influence CLSTN2 expression in hippocampal tissue, though the exact
regulatory mechanism has not been fully characterized.
The Evidence
The
original GWAS66 original GWAS
Papassotiropoulos A et al. Common Kibra alleles are
associated with human memory performance. Science, 2006
screened over 500,000 SNPs in 351 young Swiss adults and identified
rs6439886 as one of two loci associated with the best verbal episodic memory
performers (the other being KIBRA rs17070145). Carriers of the G allele —
described as the C allele in coding-strand notation — outperformed AA
homozygotes on delayed free recall. Unlike the KIBRA finding, the CLSTN2
association was not replicated in the American cohort within the same study,
suggesting possible population differences or age-dependence.
Subsequent independent studies have supported and extended the finding. A
study in 383 healthy young adults77 study in 383 healthy young adults
Preuschhof C et al. KIBRA and CLSTN2
polymorphisms exert interactive effects on human episodic memory.
Neuropsychologia, 2010
found that CLSTN2 and KIBRA genotypes interact: the G allele of CLSTN2
positively modulates memory performance in people who also carry the KIBRA
T allele. In KIBRA CC homozygotes, the CLSTN2 G allele provided no benefit
or was slightly detrimental, suggesting the two genes converge on shared
synaptic plasticity pathways.
In adolescents, a
neuroimaging study88 neuroimaging study
Jacobsen LK et al. Allelic variation of calsyntenin 2
(CLSTN2) modulates the impact of developmental tobacco smoke exposure on
mnemonic processing in adolescents. Biological Psychiatry, 2009
confirmed a beneficial effect of the G allele on verbal recall and showed
that this advantage is associated with enhanced functional connectivity
between memory-related brain regions. Crucially, developmental tobacco smoke
exposure eliminated the memory benefit and reversed the connectivity
advantage in G carriers — making this one of the first demonstrations that a
genetic memory advantage can be cancelled by environmental exposure during
a sensitive developmental period.
In older adults with unipolar depression,
a study of 2,170 people aged 60+99 a study of 2,170 people aged 60+
Pantzar A et al. Interactive effects of
KIBRA and CLSTN2 polymorphisms on episodic memory in old-age unipolar
depression. Neuropsychologia, 2014
found that the combination of KIBRA CC and CLSTN2 AA genotypes was
specifically associated with the lowest episodic memory performance among
depressed individuals. Genetic effects on cognition appear to be amplified
in populations with suboptimal cognitive reserve. A
polygenic analysis of 2,490 dementia-free older adults1010 polygenic analysis of 2,490 dementia-free older adults
Laukka EJ et al.
Combined genetic influences on episodic memory decline in older adults
without dementia. Neuropsychology, 2020
found that a composite score including APOE, BDNF, KIBRA, and CLSTN2 risk
alleles predicted faster episodic memory decline (β=-0.064, p<0.01), though
CLSTN2 alone was not significant in that cohort.
Practical Implications
The actionable picture for AA homozygotes — the most common genotype — is one of modest increased vulnerability to episodic memory decline over time, particularly in conjunction with other memory-related variants and in the presence of environmental stressors. The CLSTN2 mechanism points specifically toward GABAergic interneuron health and synaptic inhibitory-excitatory balance in the hippocampus. Strategies that support parvalbumin interneuron function, promote hippocampal neuroplasticity, and protect against age-related inhibitory circuit loss are the most mechanistically coherent interventions.
Phosphatidylserine is one of the few supplements with reasonable clinical trial evidence for verbal memory support in older adults, with double-blind placebo-controlled data showing improvement in delayed verbal recall in people with subjective memory complaints. Its mechanism — supporting neuronal membrane integrity and signaling — is complementary to CLSTN2's role in maintaining synaptic scaffolding.
Importantly, the tobacco smoke reversal of the G allele memory benefit is a reminder that genetic advantages are not immune to environmental damage, particularly during development.
Interactions
The interaction between CLSTN2 rs6439886 and KIBRA rs17070145 is well documented. The memory-enhancing effect of the CLSTN2 G allele is contingent on the KIBRA T allele being present; in KIBRA CC homozygotes, CLSTN2 G provides no benefit and may be mildly detrimental. Both proteins operate in hippocampal synaptic plasticity pathways — KIBRA through PKMzeta-mediated long-term potentiation, CLSTN2 through maintenance of parvalbumin interneuron density. The combination of KIBRA CC and CLSTN2 AA (both risk-direction genotypes) is associated with the lowest episodic memory performance in studies of older adults with depression. This interaction is a candidate for a compound action: individuals carrying both KIBRA CC and CLSTN2 AA genotypes face additive risk and may benefit from more aggressive memory-supportive strategies than either variant alone would suggest.
Genotype Interpretations
What each possible genotype means for this variant:
Common genotype with average episodic memory baseline
The AA genotype at rs6439886 is the most common configuration globally, with the A allele present at approximately 87% frequency in European populations and 82-91% across major ancestry groups. In the original 2006 GWAS, AA homozygotes were in the reference group against which G-allele carriers were compared in the Swiss cohort. The association between this variant and memory failed to replicate in the American cohort of the same study, suggesting the effect may be modest, population- specific, or age-dependent.
The CLSTN2 mechanism is relevant to long-term hippocampal health: mouse models show that loss of CLSTN2 function reduces parvalbumin-positive GABAergic interneurons by 25-56% in the hippocampus. While the human intronic variant has a much subtler effect than complete gene deletion, it points toward inhibitory circuit integrity as the relevant biological pathway. The polygenic study by Laukka et al. (2020) suggests that the AA genotype contributes modestly to memory decline risk when combined with risk alleles at APOE, BDNF, and KIBRA.
For AA homozygotes, the most meaningful intervention is ensuring that co-occurring risk factors — other memory-related genotypes, cardiovascular risk factors, depression, and inflammatory burden — are managed proactively.
One copy of the memory-associated G allele
Heterozygous AG individuals carry one G allele, the less common variant associated with better verbal memory in the original Papassotiropoulos et al. (2006) Science study and replicated in adolescents and older adults. The 2010 Preuschhof et al. study in 383 healthy young adults showed that the CLSTN2 G allele boosted the memory benefits of the KIBRA T allele, with the combined effect largest on complex associative memory tasks. In the AG genotype, one copy of CLSTN2 produces the G-variant protein, which may support modestly better hippocampal parvalbumin interneuron density compared to AA, though heterozygous effects have not been directly measured in human neuroimaging studies.
The adolescent tobacco smoke study by Jacobsen et al. (2009) is worth noting: among G-allele carriers, developmental tobacco smoke exposure reversed the memory advantage and disrupted functional connectivity between memory-relevant brain regions. This makes this variant one of the few memory-related SNPs where a documented environmental exposure can eliminate the genetic benefit.
Two copies of the memory-associated G allele
GG homozygotes represent the minor-allele homozygous state for rs6439886, with a global frequency of approximately 1-2% and somewhat higher in African-ancestry populations (~3%). Two copies of the G allele would be expected to maximize CLSTN2 expression in hippocampal tissue, supporting parvalbumin interneuron density and inhibitory-excitatory balance throughout the hippocampus and temporal cortex.
The rarity of this genotype means it has rarely been analyzed separately from heterozygous AG carriers in published studies — most studies combine AG and GG into a "G-carrier" group. The effect observed in G carriers overall — better verbal recall, enhanced parahippocampal connectivity during memory tasks, and protection against the KIBRA CC memory deficit — should apply at least as strongly to GG homozygotes, though direct evidence specifically in GG individuals is limited due to small sample sizes.
Even with the GG genotype, developmental tobacco smoke exposure eliminates the memory advantage (per the Jacobsen et al. 2009 study), underscoring that the genetic benefit requires an intact hippocampal environment to manifest.
Key References
Papassotiropoulos et al. 2006 — Science GWAS identifying CLSTN2 rs6439886 as a secondary memory-associated locus alongside KIBRA; C-allele carriers showed better verbal recall in the Swiss discovery cohort
Preuschhof et al. 2010 — KIBRA and CLSTN2 polymorphisms exert interactive effects on episodic memory (N=383); CLSTN2 C-allele boosted KIBRA T-allele memory benefit
Jacobsen et al. 2009 — CLSTN2 C-allele confers a beneficial effect on verbal recall in adolescents that is reversed by developmental tobacco smoke exposure (Biological Psychiatry)
Pantzar et al. 2014 — Interactive effects of KIBRA and CLSTN2 on episodic memory in old-age unipolar depression (N=2,170); KIBRA CC + CLSTN2 AA combination associated with poorest performance
Lipina et al. 2016 — CLSTN2-deficient mice show spatial memory deficits, reduced parvalbumin-positive GABAergic interneurons in hippocampus (25-56%), and selective reduction of inhibitory synapses
Laukka et al. 2020 — Combined genetic score across APOE, BDNF, KIBRA, and CLSTN2 predicts faster episodic memory decline in 2,490 dementia-free older adults (regression β=-0.064, p<0.01)